FDA approves Roche’s MRSA test, allowing for faster screeningThe FDA has approved Roche’s MRSA test, a technology that could give healthcare providers the ability to detect Share XFDA approves Roche’s MRSA test, allowing for faster screeninghttps://pharmaphorum.com/news/fda-approves-roches-mrsa-test/
UK should pay $25 million for ‘Netflix’ antibiotic subscriptionAn expert has said the UK must pay upwards of $25 million per year to drug companies developing Share XUK should pay $25 million for ‘Netflix’ antibiotic subscriptionhttps://pharmaphorum.com/news/uk-should-pay-at-least-25-million-for-netflix-antibiotic-subscription-says-expert/
Experts concerned over mixed results from Takeda’s dengue vaccineTakeda’s dengue vaccine has met its target of protection against the disease in children – but there are Share XExperts concerned over mixed results from Takeda’s dengue vaccinehttps://pharmaphorum.com/news/experts-concerned-over-mixed-results-from-takedas-dengue-vaccine/
GSK sells travel vaccines to Bavarian NordicGlaxoSmithKline (GSK) has sold off two travel vaccines to Bavarian Nordic, as the company shifts its focus away Share XGSK sells travel vaccines to Bavarian Nordichttps://pharmaphorum.com/news/gsk-sells-travel-vaccines-to-bavarian-nordic/
UK trial investigates whether antibiotics could cut miscarriage likelihoodUK researchers are beginning a trial investigating whether a course of antibiotics prior to conceiving could cut likelihood Share XUK trial investigates whether antibiotics could cut miscarriage likelihoodhttps://pharmaphorum.com/news/uk-trial-investigates-whether-antibiotics-could-cut-miscarriage-likelihood/
Merck & Co in pole position for Ebola vaccine approval as FDA begins reviewThe FDA is to review Merck & Co’s Ebola vaccine, giving the US pharma a chance to grab Share XMerck & Co in pole position for Ebola vaccine approval as FDA begins reviewhttps://pharmaphorum.com/news/fda-to-review-merck-cos-ebola-vaccine/
ViiV’s injection still suppresses HIV when taken every two months – studyGSK’s ViiV Healthcare joint venture has announced data backing an injection taken that can suppress the HIV virus Share XViiV’s injection still suppresses HIV when taken every two months – studyhttps://pharmaphorum.com/news/viivs-injection-still-suppresses-hiv-when-taken-every-two-months-study/
Not-for-profit gets tuberculosis drug approved ahead of big pharmaThe FDA has approved a new drug to treat certain types of multi-drug resistant tuberculosis – but it’s Share XNot-for-profit gets tuberculosis drug approved ahead of big pharmahttps://pharmaphorum.com/news/not-for-profit-tb-alliance-gets-new-tb-drug-approved/
Gilead’s R&D chief to step down as new CEO O’Day rings the changesGilead’s chief scientific officer, John McHutchison is to leave the company at the beginning of next month during Share XGilead’s R&D chief to step down as new CEO O’Day rings the changeshttps://pharmaphorum.com/news/gileads-rd-chief-to-step-down-as-new-ceo-oday-rings-the-changes/
